T45.693
Poisoning by other fibrinolysis-affecting drugs, assault
Clinical Classification Guidelines
Medical Intelligence & Overview
Poisoning by other fibrinolysis-affecting drugs, classified under ICD-10 Code T45.693, refers to cases where an individual experiences toxic effects due to the improper or accidental use of medications that influence the process of fibrinolysis— the body's mechanism for breaking down blood clots. Fibrinolytic drugs are vital in managing conditions like blood clots, heart attacks, and strokes; however, misuse or overdose can lead to serious health complications. This article provides insights into what constitutes this condition, its causes, symptoms, diagnosis, and general approach to treatment.
Causes & Symptoms
Clinical Causes: Accidental overdose of fibrinolytic medications prescribed for medical conditions Intentional misuse or abuse of fibrinolytic agents Incorrect administration or dosage of blood-thinning drugs affecting fibrinolysis Drug interactions leading to increased fibrinolytic activity Inadequate understanding of medication instructions
Key Symptoms: Unusual bleeding or hemorrhage, such as nosebleeds or bleeding gums Bruising easily Heavy or prolonged menstrual bleeding Signs of internal bleeding, including abdominal pain and weakness Hypotension (low blood pressure) Dizziness or fainting Symptoms of shock in severe cases Skin petechiae or hematomas
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive clinical evaluation, reviewing medication history, and laboratory testing. Blood tests such as coagulation profiles, fibrinogen levels, and platelet counts are crucial in assessing the extent of bleeding risk. Imaging studies may be necessary if internal bleeding is suspected. Healthcare providers also monitor for signs of ongoing bleeding or clotting abnormalities to confirm the diagnosis of fibrinolytic drug poisoning.
Treatment Protocols: Discontinuation of the offending medication Supportive care to maintain blood pressure and organ function Administration of reversal agents, such as antifibrinolytic drugs like tranexamic acid or aminocaproic acid, to counteract excessive fibrinolysis Blood transfusions or plasma infusion to replace lost blood components Monitoring and correction of coagulopathy through laboratory tests Surgical intervention if bleeding is uncontrolled or internal bleeding is identified
Clinical Advice & FAQs
Billing Guidance
Is T45.693 a billable ICD-10 code?
Yes, T45.693 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T45.693?
Clinical documentation must specify the nature of Poisoning by other fibrinolysis-affecting drugs, assault and any associated comorbidities for accurate reporting.
Cite this Clinical Reference